Explain this page
Arphra AIPlain-English read on Bristol-Myers Squibb Company’s valuation06-03today
- Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?2d
- Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today3d
- Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.3d
- Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?3d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$483.58
+746.46% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
15bull2bear
±5% threshold
Analyst PT consensus: $62.00 (+8.52%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.40% | +0.87% | +0.23% | -3.30% | +5.23% | +5.91% | +17.41% | -11.66% | -15.26% | -21.28% | +2714.29% |
Insider · 30d
History →Bought
$202.22K
1 txn
Sold
$4.52M
5 txns
Net flow
−$4.32M
Aftermarket
LiveLast trade
$56.91
2,011 sh
Bid
$56.00
1 sh
Ask
$57.75
40 sh
Spread
$1.750
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $11.49B | $2.68B | $1.31 |
| Q4 Dec 2025 | $12.5B | $1.09B | $0.53 |
| Q3 Sep 2025 | $12.22B | $2.2B | $1.08 |
| Q2 Jun 2025 | $12.27B | $1.31B | $0.64 |
| Q1 Mar 2025 | $11.2B | $2.46B | $1.20 |
| Q4 Dec 2024 | $12.34B | $72M | $0.04 |
Sector & industry today
LiveSectors
- Utilities+2.58%
- Energy+1.31%
- Basic Materials+0.81%
- Consumer Defensive+0.72%
- Technology+0.67%
- Real Estate+0.47%
- Financial Services+0.33%
- Industrials+0.06%
- Consumer Cyclical-0.34%
- Communication Services-0.77%
- Healthcare-1.62%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-2.21%
- Broadcasting-4.06%
- Coal+3.67%
- Renewable Utilities+3.61%
- Silver+3.21%
- Computer Hardware+2.54%
- Medical - Equipment & Services-2.31%
- Oil & Gas Energy+2.30%
- Auto - Dealerships-2.28%
- Copper+2.24%
- Medical - Healthcare Information Services-2.20%
- Oil & Gas Exploration & Production+2.18%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$62.00
+8.52% upside
Low
$40.00
Median
$60.00
High
$75.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?zacks.com·Jun 12, 2026
- Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Todayzacks.com·Jun 11, 2026
- Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.fool.com·Jun 11, 2026
- Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?zacks.com·Jun 11, 2026
- Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trialreuters.com·Jun 11, 2026
- Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 09, 2026
- Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Knowzacks.com·Jun 05, 2026
- Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stockfool.com·Jun 05, 2026
Peers
Total assets
$90.04B
Total debt
$47.14B
Cash & equiv
$10.21B
Operating CF
$14.16B
Free cash flow
$12.85B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Elkins David V officer: EVP, Chief Financial Officer | Sell | 4,481 | $278.05K | Apr 01, 2026 |
Elkins David V officer: EVP, Chief Financial Officer | Sell | 25,519 | $1.57M | Apr 01, 2026 |
Elkins David V officer: EVP, Chief Financial Officer | Sell | 56,000 | $2.65M | Sep 02, 2025 |
Short Bartie Wendy officer: EVP, Corporate Affairs | Sell | 378 | $16.72K | Aug 02, 2025 |
Hickey Benjamin officer: President, RayzeBio Org. | Sell | 97 | $3.7K | May 09, 2025 |
Hirawat Samit officer: EVP,Chief Med.Offr.,Drug Dev. | Buy | 4,250 | $202.22K | Apr 25, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $48.19B | $12.7B | $7.05B | $3.45 | +14.63% |
| FY 2024 | $48.3B | $9.66B | -$8.95B | $-4.41 | -18.53% |
| FY 2023 | $45.01B | $8.47B | $8.03B | $3.86 | +17.83% |
| FY 2022 | $46.16B | $9.27B | $6.33B | $2.95 | +13.71% |
| FY 2021 | $46.39B | $9.54B | $6.99B | $3.12 | +15.08% |